Medicare Enrolled
Dr. Jeffrey Tyler, M.D.
Interventional Cardiology · Orange, CA
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tyler from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tyler?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tyler
Dr. Jeffrey Tyler is an interventional cardiology specialist in Orange, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Tyler performed 2,613 Medicare services across 1,730 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tyler received a total of $311,243 from 41 pharmaceutical and/or device companies across 639 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tyler is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 45% volume in CA
$311,243 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,613
Medicare services
Top 45% in CA for interventional cardiology
1,730
Unique beneficiaries
$203
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~218 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
460 | $44 | $122 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
398 | $109 | $277 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 224 | $417 | $1,050 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
181 | $13 | $32 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
136 | $102 | $244 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
114 | $64 | $156 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
112 | $1,740 | $4,400 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
103 | $163 | $449 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
86 | $131 | $359 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
84 | $12 | $29 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
79 | $10 | $25 |
| Cardiac catheterization | 67 | $192 | $594 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
62 | $125 | $310 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
58 | $22 | $53 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
58 | $148 | $375 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
57 | $801 | $1,989 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
44 | $169 | $442 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
33 | $88 | $224 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
30 | $78 | $192 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
28 | $181 | $454 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
26 | $47 | $124 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
26 | $22 | $54 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
26 | $200 | $527 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $152 | $387 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
23 | $6 | $16 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
18 | $427 | $1,181 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
17 | $73 | $178 |
| Mitral valve repair through skin, initial prosthesis A minimally invasive procedure to repair the mitral valve using a new prosthetic device inserted through the skin. |
13 | $900 | $3,645 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $67 | $199 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
12 | $21 | $52 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.2% high complexity
36.0% medium
53.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$311,243
Total received (2018-2024)
Avg $44,463/year across 7 years
Top 3% in CA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
639
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$246,015 (79.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$34,048 (10.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,994 (5.1%)
Scientific / Research
Research funding and grants
$15,186 (4.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$126,965
2023
$107,521
2022
$53,281
2021
$5,933
2020
$17,195
2019
$121
2018
$226
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ShockWave Medical, Inc
$64,380
ABIOMED
$45,024
Abbott Laboratories
$12,028
W. L. Gore & Associates, Inc.
$1,860
ATRICURE, INC.
$1,153
Medtronic, Inc.
$706
Edwards Lifesciences Corporation
$617
Boston Scientific Corporation
$355
Novartis Pharmaceuticals Corporation
$191
E.R. Squibb & Sons, L.L.C.
$179
Merck Sharp & Dohme LLC
$141
AstraZeneca Pharmaceuticals LP
$120
Amgen Inc.
$80
CARDIVA MEDICAL, INC.
$26
Philips North America LLC
$19
Lilly USA, LLC
$18
Novo Nordisk Inc
$18
SANOFI-AVENTIS U.S. LLC
$17
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$17
SCPHARMACEUTICALS INC.
$16
Top 3 companies account for 95.6% of 2024 payments
All-time payments by company (2018-2024) ›
ShockWave Medical, Inc
$104,769
ABIOMED
$101,447
Abbott Laboratories
$22,012
Cardiovascular Systems Inc.
$19,645
ATRICURE, INC.
$16,080
Medtronic Vascular, Inc.
$15,186
Shockwave Medical, Inc
$11,380
Edwards Lifesciences Corporation
$10,165
W. L. Gore & Associates, Inc.
$1,860
Boston Scientific Corporation
$1,779
Medtronic, Inc.
$1,498
Penumbra, Inc.
$1,015
BOSTON SCIENTIFIC CORPORATION
$726
Amgen Inc.
$558
Novartis Pharmaceuticals Corporation
$527
AstraZeneca Pharmaceuticals LP
$345
Philips Electronics North America Corporation
$235
BIOTRONIK INC.
$227
Boehringer Ingelheim Pharmaceuticals, Inc.
$189
E.R. Squibb & Sons, L.L.C.
$179
Saranas, Inc.
$167
Astellas Pharma US Inc
$164
Merck Sharp & Dohme LLC
$153
AtriCure, Inc.
$142
Avinger Inc.
$124
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$88
PFIZER INC.
$68
Baxter Healthcare
$62
Terumo Medical Corporation
$61
CVRx, Inc.
$60
SANOFI-AVENTIS U.S. LLC
$58
GlaxoSmithKline, LLC.
$56
SCPHARMACEUTICALS INC.
$48
Siemens Medical Solutions USA, Inc.
$44
CARDIVA MEDICAL, INC.
$26
Philips North America LLC
$19
Lilly USA, LLC
$18
Novo Nordisk Inc
$18
iRhythm Technologies, Inc.
$18
Ultragenyx Pharmaceutical Inc.
$17
Kowa Pharmaceuticals America, Inc.
$13
Top 3 companies account for 73.3% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (6342) Intrasight Integ · (6342) Intrasight Integrated · (6572) Rotational · (6585) Omniwire · (9267) AngioSculpt CV RX · (P84) IGT Devices Systems · 2ND GEN CENTRIMAG PRIMARY CONSOLE · 3F · ACUITY Steerable · ACUSON SC2000 Diagnostic Ultrasound System · ATRICLIP LAA EXCLUSION SYSTEM · AVEIR · AVVIGO · AVVIGO Guidance System · AngioSeal · Artis icono floor · BENLYSTA · BRILINTA · Barostim Neo System · Baylis Medical Company Radiofrequency Puncture Generator · CAMZYOS · CARDIOMEMS · COMET · COREVALVE EVOLUT R · COROFLOW · CoreValve Evolut · Coronary Orbital Atherectomy System · DIAMONDBACK CORONARY · DIAMONDBACK PERIPHERAL · DRAGONFLY OPSTAR · Diamondback Coronary · Diamondback Peripheral · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMBLEM MRI S-ICD · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVOQUE · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Endurant · FARXIGA · FUROSCIX · GENERAL ATHERECTOMY · GENERAL STENTS · GENERAL THERAPIES · GENERAL ATHERECTOMY · GENERAL - ATHERECTOMY · GENERAL - STENTS · GENERAL - STRUCTURAL HEART · GENERAL - THERAPIES · GENERAL STENTS · GORE CARDIOFORM Septal Occluder · General - Therapies · HORNET · Hillrom - Cardiac Ambulatory Monitor · Impella · Indigo System · JARDIANCE · LEQVIO · LOTUS EDGE · LifeVest · Livalo · MAMBA · MITRACLIP · MOUNJARO · MULTAQ · OPTICROSS · OPTIS · Orsiro · Ozempic · PANTHERIS · PASCAL · PORTICO · PRO-Kinetic Energy · Portico Transcatheter Aortic Heart Valve · Pulsar · R2P MISAGO · Repatha · S-ICD System Magnet · SAPIEN 3 Ultra RESILIA · SAVVYWIRE · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYNERGY · SYNERGY ABLATION SYSTEM · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · VERQUVO · VYNDAQEL · Vascular Lithotripsy · WAINUA · WATCHMAN Access System · WATCHMAN FLX · WINREVAIR · XIENCE SKYPOINT · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (79%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional cardiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for interventional cardiology in CA.
Geographic Context
Interventional cardiologists within 10 mi
66
Per 100K population
2.1
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JOSEPH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tyler is a cardiac imaging specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 3% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tyler experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Tyler performed 460 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tyler receive payments from pharmaceutical companies?
Yes. Dr. Tyler received a total of $311,243 from 41 companies across 639 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tyler's costs compare to other interventional cardiologists in Orange?
Dr. Tyler's average Medicare payment per service is $203. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tyler) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Orange
Browse interventional cardiologists in Orange ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
ShockWave Medical, Inc Payments to Doctors
See all physicians who received payments from ShockWave Medical, Inc.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology